Tadehaginoside, a phenylpropanoid glycoside, regulates adipogenesis and glucose consumption and possesses antioxidant properties. By modulating the Nrf2 and NF-κB signaling pathways in hepatic cells, Tadehaginoside acts as a liver protectant, preventing oxidative stress damage and inflammation. It is applicable in the study of obesity and diabetes.